PO150 Memory b cells are key for immunotherapy in multiple sclerosis
Abstract
Although multiple sclerosis (MS) is considered to be a CD4+,Th17-mediated autoimmune disease, supportive evidence is largely circumstantial and often based on animal studies. Whilst alemtuzumab inhibits relapsing MS and depletes CD4+ T cells, it also selectively depletes CD19+,CD27+ memory B cells. Although CD4-depletion is considered to have failed in MS, we found following extensive review of the relevant literature and data mining that...
Paper Details
Title
PO150 Memory b cells are key for immunotherapy in multiple sclerosis
Published Date
Dec 1, 2017
Volume
88
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History